Medicaid bans coverage for gender-affirming care for minors
Medicaid bans coverage for gender-affirming care for minors
Updated at: August 13, 2026 at 02:35 AM
As of August 2026, the U.S. healthcare landscape faces a major shift regarding transgender youth.
The Trump administration has announced a federal rule through the Centers for Medicare & Medicaid Services (CMS) that bans the use of Medicaid and CHIP funds for gender-affirming care for minors.
This mandate, taking effect October 13, 2026, prohibits coverage for surgeries and hormone treatments, including puberty blockers.
Mehmet Oz justified the policy by labeling these medical procedures as potentially harmful to children.
Conversely, leading medical groups like the American Academy of Pediatrics maintain that such care is medically necessary, and organizations like the ACLU have promised to challenge the rule in court.
This federal action complicates an already divided landscape, as at least 27 states had already implemented their own bans prior to this announcement.
As Medicaid is a joint federal-state program, the future of these services remains uncertain, with potential conflicts emerging in states that previously offered protective access.
The policy marks a significant escalation in the ongoing legal and ethical debates surrounding gender-affirming care in the United States.
